Loading…
← CockpitCompetitor Analysis › 300082.SZ Liaoning Oxiranchem,Inc. Class AOpen in the cockpit ↗

Liaoning Oxiranchem,Inc. Class A300082.SZCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Major Diversified
Momentum weak 34
Mkt cap
$716M
US dollars, full cap
Free float
47%
of shares outstanding
$/day
$12.1M
20-day average traded
Fwd P/E
35.1×
forward earnings
ROIC−WACC
-5.7 pp
WACC 8.5%
Hurdle
n/a
no reverse DCF
Next earnings
172 days
27 Apr 2027
Close · CNYCN¥7.02
1D-1.4%
1W+5.7%
1M-14.9%
3M+2.9%
6M-38.5%
YTD-29.1%
1Y-14.6%
ATR %4.5%
52w lowhigh51.2% off high

What Liaoning Oxiranchem,Inc does

Employees: 1,362

Liaoning Oxiranchem,Inc at a glance

Size Liaoning Oxiranchem,Inc (300082.SZ) is a China Materials company (Chemicals: Major Diversified) with a market value of $716M, the 3016th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥7.02 on 6 Nov 2026.

Performance Over six months the shares fell 38.5%, against -18.1% for the median peer and -16.4% for the China market (cap-weighted) — 5th lowest of 21 in its peer set.

Growth Revenue grew 4.3% over the last twelve months (peer median +6.9%); the operating margin is 0.4% (peer median 7.5%).

Valuation It trades at 35.1× forward earnings against a peer median of 21.8× (4th most expensive of 13).

Capital Return on invested capital runs 5.7 points below its cost of capital (8.5% WACC).

Next results Next results expected around 27 Apr 2027 (exchange calendar; dates can move).

Relative performance

608010012011 May 202611 Aug 20266 Nov 2026Peer median 82300082.SZ 61
Six months, rebased to 100: Liaoning Oxiranchem,Inc against the median of its 20 peers (local-currency closes).

Liaoning Oxiranchem,Inc financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥4.60BCN¥4.22BCN¥4.27BCN¥3.79BCN¥5.62B
Revenue growth—-1%+13%-33%—
Gross profitCN¥400MCN¥169MCN¥71.2M-CN¥98.4MCN¥204M
EBITDAn/aCN¥168MCN¥84.4MCN¥4.73MCN¥314M
Net incomeCN¥106MCN¥6.80M-CN¥159M-CN¥309MCN¥5.60M
Free cash flow-CN¥107M-CN¥486M-CN¥65.9MCN¥20.3MCN¥51.5M
Capital expenditureCN¥32.5MCN¥20.6MCN¥28.2MCN¥70.0MCN¥258M
Total debtCN¥2.00BCN¥1.97BCN¥1.85BCN¥1.61BCN¥1.53B

Quarterly statements and history in the cockpit →

Liaoning Oxiranchem,Inc competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%+40%-30%-20%-10%0%4189002274600165301206497552346882376031553001216032856887506053664471300530688669300839603004RPEL301393300801300082.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Liaoning Oxiranchem,Inc is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%0×100×200×4189002274497552346882376031553001216053664471300839603004301393300082.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Liaoning Oxiranchem,Inc is the large dot.

Liaoning Oxiranchem,Inc competitors and peer comparison

How Liaoning Oxiranchem,Inc compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Liaoning Oxiranchem,Inc against its 20 peers (data as of 6 Nov 2026)
Measure300082.SZPeer medianRank in peer set
1-month return-14.9%-14.4%10th lowest of 21
6-month return-38.5%-18.1%5th lowest of 21
Distance from 52-week high-51.2%-38.1%5th lowest of 21
Revenue growth (TTM)+4.3%+6.9%10th lowest of 21
Operating margin0.4%7.5%6th lowest of 21
Forward P/E35.1×21.8×4th most expensive of 13
ROIC minus cost of capital-5.7 pp-1.7 pp7th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Liaoning Oxiranchem,Inc 300082.SZChina$716M-39%+4%0%35.1×n/an/a
KH Neochem 4189.TJapan$732M+20%-11%12%12.3×-5.7%+8.3%
Jiansu Huachang Chemical 002274.SZChina$679M-25%+9%-3%5.7×23.6%+1.3%
Ningxia Zhongke Biotechnology 600165.SSChina$679M-19%+8%-73%n/an/an/a
Shandong Sanyuan Biotechnology 301206.SZChina$676M-18%+15%4%n/an/an/a
JCU 4975.TJapan$759M-26%+2%40%13.6×6.3%+7.0%
Daxin Materials 5234.TWTaiwan$767M-42%+10%19%25.7×17.7%+1.5%
Hubei Chaozhuo Aviation Technology 688237.SSChina$776M+6%-1%1%41.5×45.3%+26.0%
Xinyaqiang Silicon Chemistry 603155.SSChina$788M-6%+6%10%37.0×31.1%+3.9%
Shandong Yanggu Huatai Chemical 300121.SZChina$648M-20%+11%8%16.1×3.2%+12.1%
Shandong Jianbang New Material 603285.SSChina$631M-40%+8%22%n/an/an/a
Hunan Xiangtou Goldsky Titanium Industry Technology 688750.SSChina$629M-27%+4%6%n/a30.5%-4.3%
Jiangxi Hungpai New Material 605366.SSChina$821M-47%+2%-11%236.0×n/an/a
Sanyo Chemical Industries 4471.TJapan$823M+24%0%10%10.5×-5.1%-2.5%
Hunan Lead Power Technology 300530.SZChina$621M+2%+16%-61%n/an/an/a
Polyrocks Chemical 688669.SSChina$831M+40%-8%-6%n/a35.9%+15.2%
Ningbo Bohui Chemical Technology 300839.SZChina$606M-4%+42%4%24.6×3.2%+23.1%
Zhejiang Dragon Technology 603004.SSChina$597M-18%-11%16%19.1×16.4%+1.7%
Raghav Productivity Enhancers RPEL.NSIndia$864M+133%+38%28%n/an/an/a
Suzhou Highfine Biotech 301393.SZChina$865M-8%+36%17%32.3×n/an/a
Shandong Taihe Technologies 300801.SZChina$589M-41%-2%7%n/a5.3%+12.9%

Questions

Which companies are Liaoning Oxiranchem,Inc's closest peers?
The cockpit's peer set: KH Neochem (4189.T), Jiansu Huachang Chemical (002274.SZ), Ningxia Zhongke Biotechnology (600165.SS), Shandong Sanyuan Biotechnology (301206.SZ), JCU (4975.T), Daxin Materials (5234.TW), Hubei Chaozhuo Aviation Technology (688237.SS), Xinyaqiang Silicon Chemistry (603155.SS).
Is Liaoning Oxiranchem,Inc expensive compared with its peers?
On forward p/e it trades at 35.1× against a peer median of 21.8×, 4th most expensive of 13 in its peer set.
How has Liaoning Oxiranchem,Inc stock performed?
Over six months to 6 Nov 2026 the shares returned -38.5% against -18.1% for the median peer; over one year -14.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.